Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2012, Article ID 929052, 9 pages
http://dx.doi.org/10.1155/2012/929052
Research Article

The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells

1Department of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN 37208, USA
2Basic Science and Craniofacial Biology, New York University College of Dentistry, 345 East 24th Street, New York City, NY 10010, USA

Received 1 September 2011; Revised 22 November 2011; Accepted 23 November 2011

Academic Editor: R. P. Phipps

Copyright © 2012 Adrienne Bolden et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [27 citations]

The following is the list of published articles that have cited the current article.

  • Yong Sung Park, Wei Guang, Thomas G. Blanchard, K. Chul Kim, and Erik P. Lillehoj, “Suppression of IL-8 production in gastric epithelial cells by MUC1 mucin and peroxisome proliferator-associated receptor-γ,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 303, no. 6, pp. G765–G774, 2012. View at Publisher · View at Google Scholar
  • Sakshi Sikka, Luxi Chen, Gautam Sethi, and Alan Prem Kumar, “Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer,” PPAR Research, vol. 2012, pp. 1–14, 2012. View at Publisher · View at Google Scholar
  • Shailendra Kapoor, “Troglitazone and tumor inhibition: an evolving concept in the management of systemic malignancies,” Radiation Oncology Journal, vol. 30, no. 4, pp. 226, 2012. View at Publisher · View at Google Scholar
  • Misael Ferreira, Laura Sartori Assunção, Fabíola Branco Filippin-Monteiro, Tânia Beatriz Creczynski-Pasa, and Marcus Mandolesi Sá, “Synthesis of 1,3-thiazine-2,4-diones with potential anticancer activity,” European Journal of Medicinal Chemistry, 2013. View at Publisher · View at Google Scholar
  • Jennifer H. Gunter, Phoebe L. Sarkar, Amy A. Lubik, and Colleen C. Nelson, “New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication,” International Journal of Cell Biology, vol. 2013, pp. 1–13, 2013. View at Publisher · View at Google Scholar
  • Shin-Jen Lin, Yanqing Zhang, Ning-Chun Liu, Dong-Rong Yang, Gonghui Li, and Chawnshang Chang, “Minireview: Pathophysiological Roles of the TR4 Nuclear Receptor: Lessons Learned From Mice Lacking TR4,” Molecular Endocrinology, vol. 28, no. 6, pp. 805–821, 2014. View at Publisher · View at Google Scholar
  • S Yan, X Yang, T Chen, Z Xi, and X Jiang, “The PPARγ agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells,” Cancer Gene Therapy, vol. 21, no. 5, pp. 188–193, 2014. View at Publisher · View at Google Scholar
  • Werner J. Geldenhuys, Thomas C. Leeper, and Richard T. Carroll, “mitoNEET as a novel drug target for mitochondrial dysfunction,” Drug Discovery Today, 2014. View at Publisher · View at Google Scholar
  • Swei Sunny Hahn, Qing Tang, Fang Zheng, Shunyu Zhao, and JingJing Wu, “GW1929 inhibits α7 nAChR expression through PPARγ-independent activation of p38 MAPK and inactivation of PI3-K/mTOR: The role of Egr-1,” Cellular Signalling, 2014. View at Publisher · View at Google Scholar
  • Mohd. Marsin Sanagi, Imran Ali, Mohammad Nadeem Lone, Zeid A. Al-Othman, and Abdulrahman Al-Warthan, “Heterocyclic scaffolds: Centrality in anticancer drug development,” Current Drug Targets, vol. 16, no. 7, pp. 711–734, 2015. View at Publisher · View at Google Scholar
  • Zili Zhang, Mei Guo, Shifeng Zhao, Wenxuan Xu, Jiangjuan Shao, Feng Zhang, Li Wu, Yin Lu, and Shizhong Zheng, “The update on transcriptional regulation of autophagy in normal and pathologic cells: A novel therapeutic target,” Biomedicine & Pharmacotherapy, 2015. View at Publisher · View at Google Scholar
  • Shin-Jen Lin, Chang-Yi Lin, Dong-Rong Yang, Kouji Izumi, Emily Yan, Xiaodan Niu, Hong-Chiang Chang, Hiroshi Miyamoto, Nancy Wang, Gonghui Li, and Chawnshang Chang, “The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status,” Neoplasia, vol. 17, no. 4, pp. 339–347, 2015. View at Publisher · View at Google Scholar
  • Vinicius G. Maltarollo, Marie Togashi, Alessandro S. Nascimento, and Kathia M. Honorio, “Structure-Based Virtual Screening and Discovery of New PPAR delta/gamma Dual Agonist and PPAR delta and gamma Agonists,” Plos One, vol. 10, no. 3, 2015. View at Publisher · View at Google Scholar
  • Amreen Mughal, Dinesh Kumar, and Ajit Vikram, “Effects of Thiazolidinediones on Metabolism and Cancer: Relative influence of PPARγ and IGF-1signaling,” European Journal of Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Miriam R. Reynolds, and Brian F. Clem, “Troglitazone suppresses glutamine metabolism through a PPAR-independent mechanism,” Biological Chemistry, vol. 396, no. 8, 2015. View at Publisher · View at Google Scholar
  • Li-Han Chin, Sung-Po Hsu, Wen-Bin Zhong, and Yu-Chih Liang, “Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells.,” PloS one, vol. 10, no. 3, 2015. View at Publisher · View at Google Scholar
  • Ulf Lützen, Yi Zhao, Katja Lucht, Maaz Zuhayra, Marlies Marx, Ingolf Cascorbi, and Juraj Culman, “Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism,” Naunyn-Schmiedeberg's Archives of Pharmacology, 2016. View at Publisher · View at Google Scholar
  • David J. Adams, Hing Y. Leung, Imran Ahmad, Ernest Mui, Laura Galbraith, Rachana Patel, Ee Hong Tan, Mark Salji, Alistair G. Rust, Peter Repiscak, Ann Hedley, Elke Markert, Carolyn Loveridge, Louise van der Weyden, Joanne Edwards, and Owen J. Sansom, “ Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer ,” Proceedings of the National Academy of Sciences, pp. 201601571, 2016. View at Publisher · View at Google Scholar
  • Mbo Chagas, Ncc Cordeiro, Kmr Marques, Mg Rocha Pitta, Mjbm Rêgo, Mca Lima, Mgr Pitta, and Ir Pitta, “New thiazacridine agents: Synthesis, physical and chemical characterization, and in vitro anticancer evaluation,” Human & Experimental Toxicology, vol. 36, no. 10, pp. 1059–1070, 2016. View at Publisher · View at Google Scholar
  • Donglei Liu, Yu Qi, Chunyang Zhang, Jia Zhao, Song Zhao, Kai Wu, and Yang Yang, “Activation of PPARη suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway,” Oncotarget, vol. 7, no. 28, pp. 44572–44582, 2016. View at Publisher · View at Google Scholar
  • Linjing Shu, Renhuan Huang, Songtao Wu, Zhaozhao Chen, Ke Sun, Yan Jiang, and Xiaoxiao Cai, “PPAR gamma and Its Ligands: Potential Antitumor Agents in the Digestive System,” Current Stem Cell Research & Therapy, vol. 11, no. 3, pp. 274–281, 2016. View at Publisher · View at Google Scholar
  • Qiang Zhang, Jingjing Huang, Junping Yu, Zhongmin Xu, Liang Liu, Yajing Song, Xiaomei Sun, Anding Zhang, and Meilin Jin, “HP1330 Contributes to Streptococcus suis Virulence by Inducing Toll-Like Receptor 2- and ERK1/2-Dependent Pro-inflammatory Responses and Influencing In Vivo S. suis Loads,” Frontiers in Immunology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Kamel Metwally, Harris Pratsinis, and Dimitris Kletsas, “Novel 2,4- thiazolidinediones: Synthesis, in vitro cytotoxic activity, and mechanistic investigation,” European Journal of Medicinal Chemistry, 2017. View at Publisher · View at Google Scholar
  • Bahman Yousefi, Ako Azimi, Maryam Majidinia, Vahid Shafiei-Irannejad, Reza Badalzadeh, Behzad Baradaran, Nosratollah Zarghami, and Nasser Samadi, “Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells,” Tumor Biology, vol. 39, no. 10, pp. 101042831771650, 2017. View at Publisher · View at Google Scholar
  • Shalini Muralikumar, Umashankar Vetrivel, Angayarkanni Narayanasamy, and Undurti N. Das, “Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties,” Lipids in Health and Disease, vol. 16, no. 1, 2017. View at Publisher · View at Google Scholar
  • Laura Galbraith, Hing Y. Leung, and Imran Ahmad, “Lipid pathway deregulation in advanced prostate cancer,” Pharmacological Research, 2018. View at Publisher · View at Google Scholar
  • Saghar Yousefnia, Sara Momenzadeh, Farzad Seyed Forootan, Kamran Ghaedi, and Mohammad Hossein Nasr Esfahani, “The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity,” Gene, 2018. View at Publisher · View at Google Scholar